public meeting: using methods from pfdd guidance 1 and guidance 2 meeting #1
Published 2 years ago • 2.6K plays • Length 2:02:37Download video MP4
Download video MP3
Similar videos
-
1:57:53
public meeting: using methods from pfdd guidance 1 and guidance 2 meeting #2
-
2:34:13
public webinar: patient-focused drug development draft guidance 3
-
27:06
mdufa iv: accessing and using real-world and postmarket data for regulatory decision-making
-
2:18:58
public meeting: patient-focused drug development for female sexual dysfunction (part 1 of 2)
-
9:21
fda patient focused drug development meeting - overview of fda pfdd initiative
-
1:48:56
public meeting on patient focused drug development for non tuberculous mycobacterial infections pt 1
-
5:09
patients matter: giving patients a seat at the table
-
1:00:26
fda webinar: action levels for lead in food intended for babies and young children: draft guidance
-
1:02:02
2022 externally-led patient-focused drug development - informational meeting
-
2:03:29
public meeting: optimizing fda’s use of and processes for advisory committees (morning portion)
-
15:13
mdufa iv commitment: patient engagement and the science of patient input
-
1:27:38
public meeting on patient focused drug development for hiv part 1
-
1:58:49
public meeting: patient-focused drug development for chronic pain (part 1)
-
2:30:29
public meeting: patient-focused drug development for hereditary angioedema (part 1 of 2)
-
31:32
responses to submitted poster questions - drug master file (dmf) and drug substance workshop
-
2:03:08
public meeting: patient-focused drug development for neuropathic pain (part 1 of 3)
-
1:25:17
regulatory education for industry (redi) annual conference 2024: day 1 – session 1
-
20:49
2. discussion and polls at schizophrenia- el patient-focused drug development meeting by s&paa